Genourob Overview
- Founded
-
2005
- Status
-
Private
- Employees
-
21
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$105K
- Investors
-
3
Genourob General Information
Description
Manufacturer of medical devices designed to offer treatment of ligament lesions. The company's devices are used for the evaluation of the state and performance of the ligamentous structures of the knee, enabling orthopedic surgeons, sports doctors, and physiotherapists to get support in their day-to-day work during the full process of a patient's medical care.
Contact Information
Website
www.genourob.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Primary Office
- Bâtiment 60
- Rue du Chef Bataillon Henri Géret
- 53000 Laval
- France
+33 02 00 00 00 00
Genourob Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC | 20-Jun-2019 | $105K | 00.00 | 00.000 | Completed | Generating Revenue |
| 4. Angel (individual) | 29-Dec-2017 | 00000 | 00000 | 00.000 | Completed | Generating Revenue |
| 3. Secondary Transaction - Private | 00000 | Completed | Generating Revenue | |||
| 2. Later Stage VC | 01-Mar-2015 | $487K | $884K | 00.000 | Completed | Generating Revenue |
| 1. Later Stage VC | 01-Jan-2011 | $397K | $397K | 000000 | Completed | Generating Revenue |
Genourob Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | 0,000 | 000.00 | 000.00 | 00 | 000.00 | 0.000 | ||
| Ordinary Shares | 0,000 | 000.00 | 000.00 | 00 | 000.00 | 0.000 | ||
| P Shares | 47,213 | $17.36 | $17.36 | 1x | $17.36 | 30.73% |
Genourob Patents
Genourob Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| FR-3114020-B1 | Method and apparatus for the detection and therapeutic monitoring of knee ligament injuries | Active | 15-Sep-2020 | 0000000000 | |
| FR-3114020-A1 | Method and apparatus for the detection and therapeutic monitoring of knee ligament injuries | Active | 15-Sep-2020 | 0000000000 | 0 |
| EP-2699160-A1 | Apparatus and method for detecting a partial lesion of the anterior cruciate ligament of the knee | Active | 22-Apr-2011 | 00000000 | |
| EP-2699160-B1 | Apparatus for detecting a partial lesion of the anterior cruciate ligament of the knee | Active | 22-Apr-2011 | 00000000 | |
| FR-2974286-B1 | Apparatus and method for detecting partial lesion of cross ligament anterior knee | Inactive | 22-Apr-2011 | A61B5/11 |
Genourob Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Stephane Nouveau | Co-Founder, President & Chief Executive Officer | ||
| Henry Robert Ph.D | Executive, Research & Development |
Genourob Board Members (1)
| Name | Representing | Role | Since |
|---|---|---|---|
| Bertrand Distinguin | GO Capital (France) | Board Member | 000 0000 |
Genourob Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Genourob Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Pays de la Loire Participations | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Ventures West Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Siparex Group | PE/Buyout | Minority | 000 0000 | 000000 0 |